NCI encourages the cancer research community to apply for grants supported by the American Recovery and Reinvestment Act of 2009 (ARRA).
Helpful information for submitting ARRA applications can be found at the NCI FAQs and NIH FAQs pages. Please review these useful information resources in preparing your ARRA submissions.
Find information about NCI's implementation of the recovery act at www.cancer.gov/recovery.
New opportunities will be added as they become available. Please check back frequently for updates.
Download summary listing of these active announcements in Excel
|
NIH Limited Competition Opportunities for Small Businesses
Opportunities to accelerate innovative technologies and research |
Posted: June 10, 2009 |
Title: Recovery Act Limited Competition: Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3) |
Announcement Number:
RFA-OD-09-008 |
Release Date:
June 2, 2009 |
Receipt Date:
September 1, 2009 |
Description: This award will utilize the RC3 grant mechanism. The purpose of this pilot program is to address the funding gap between promising research and development (R&D) and transitioning to the market by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization. This program also aims to foster partnerships among a variety of R&D collaborators. NIH intends to commit at least $35 million to support at least 10 awards in fiscal year, but awards are contingent upon the availability of funds. Budget proposals should be limited to $1 million total costs per year for a maximum of three years.
This program is related in scope to the prior NCI SBIR Phase II Bridge Program (RFA-CA-08-021) where the scope of applications has been limited to cancer therapeutics and cancer imaging technologies. In contrast, for the BRDG-SPAN Pilot Program, applications will be considered in any technical area that is relevant to the mission of the NCI. See NIH RFA notice for submission requirements.
NCI Scientific/Research Contact
Mr. Michael Weingarten
Program Manager
National Cancer Institute (NIH)
31 Center Drive
Room 10A52
Bethesda, MD 20892
Phone: 301- 496-1550
Fax: 301- 496-7807
E-mail: mw498z@nih.gov
Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
|
Title: Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43) |
Announcement Number:
RFA-OD-09-009 |
Release Date:
June 2, 2009 |
Receipt Date:
September 1, 2009 |
Description: This award will use the Phase I SBIR (R43) award mechanism. The purpose is to invite grant applications from small businesses that propose to accelerate innovation through high risk, high reward research and development (R&D) that has commercial potential and is relevant to the mission of the NIH. Solicited applications for support for projects that have the potential to generate high impact results (e.g., products, processes or services) and/or innovative research applications, research tools, techniques, devices, inventions, or methodologies. In accord with the funding priority of this initiative to attract applicants without a history of SPIR/STTR support from NIH, the focus of the projects solicited by the FOA is on early stage technology development. NIH intends to commit at least $5 million to make approximately 20-25 awards for fiscal year 2010. Budget requests are limited to $200,000 total costs for a maximum project period of one year. See NIH RFA notice for additional information on eligibility and submission requirements.
Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
|
close
|
Administrative Notices
NCI guidelines on ARRA funding considerations for application |
Updated: April 10, 2009 |
Title: Regarding Competitive Revisions Using Recovery Act Funds for Applications Still Requiring Paper Submission |
Announcement Number:
NOT-OD-09-083 |
Release Date:
April 10, 2009 |
Receipt Date:
n/a |
Description: Guidance to applicants responding to NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications (NOT-OD-09-058) that are competitive revisions for parent awards for which the activity code of the application has not transitioned to electronic submission. This includes Program Project grants (P01), Center grants (e.g., P20, P30, P50), Cooperative Agreements (e.g., U01), Training Grants (e.g., T32) and Institutional Career Development Awards (K12).
As indicated in the notice, two additional copies of the application (e.g., P01, P30, P50, U01, U10, etc.), which will be submitted on paper, should be sent to NCI as indicated below:
Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov
In a brief cover letter, please mention NOT-OD-09-058, which is the relevant funding opportunity announcement, the NCI-funded parent grant number, and the assigned NCI program director.
|
Title: Recovery Act Notice: NIH ARRA Funding Considerations for Applications with Meritorious Scores that Fall Beyond the Pay-line |
Announcement Number:
NOT-OD-09-078 |
Release Date:
April 3, 2009 |
Receipt Date:
n/a |
Description: NIH will implement ARRA to select existing peer-reviewed, meritorious grant applications, that can be accomplished in two years or less, meet the goals of the ARRA, and meet the mission priorities of NIH.
NCI will only be considering FY 2009 applications. Applications submitted in response to NCI RFAs and Program Announcements with specific set-asides (PAS) that have already been considered and not selected for funding, will not be reconsidered for ARRA funding.
|
close
|
NIH Academic Research Enhancement Awards (AREA)
Support of small-scale projects to enhance academic research |
Updated: April 20, 2009 |
Title: Recovery Act Limited Competition: Academic Research Enhancement Award (R15) |
Announcement Number:
RFA-OD-09-007 |
Release Date:
April 20, 2009 |
Receipt Date:
(Earliest) August 24, 2009
(Final) September 24, 2009 |
Description: The purpose of the NIH Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. These AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH programs, to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale, health-related research projects proposed by faculty members of eligible, domestic institutions. See NIH RFA notice for additional information on eligibility and submission requirements. |
close
|
Competitive Revisions and Administrative Supplements
For current NIH grantees to obtain supplemental funding |
Updated: May 28, 2009 |
Title: Administrative Supplements for The Cancer Genome Atlas (TCGA) Pilot Project |
Announcement Number:
NOT-OD-09-056 |
Release Date:
May 1, 2009 |
Receipt Date:
June 1, 2009, and June 1, 2010 |
Description: Those with NCI-funded research projects may apply for an administrative supplement in support of The Cancer Genome Atlas (TCGA) to accelerate the analysis of genetic alterations in glioblastoma, ovarian, lung, and other cancer types. See NCI Guidelines for Administrative Supplements for The Cancer Genome Atlas (TCGA) Pilot Project (PDF 34KB). |
close
|
Construction/Renovation
Support for the renovation, repair, or improvement of core facilities |
Updated: March 5, 2009 |
Title: Recovery Act Limited Competition: Core Facility Renovation, Repair, and Improvement (G20) |
Announcement Number:
RFA-RR-09-007 |
Release Date:
March 5, 2009 |
Receipt Date:
September 17, 2009 |
Description: These funds support renovations, repairs, or improvements to Public Health Service core facilities that support biomedical and/or behavioral research. A core facility is defined as a centralized, shared resource that provides access to instruments or technologies or services, as well as expert consultation to investigators supported by the facility. |
close
|
Closed Announcements
Find closed announcements for all categories, including Challenge Grants, Grand Opportunities, and Core Center grants. |
Updated: June 15, 2009 |
NIH National Center on Minority Health and Health Disparities (NCMHD) Awards
Title: Recovery Act Limited Competition: NCMHD Community Participation in Health Disparities Intervention Research Planning Phase (R24) |
Announcement Number:
RFA-MD-09-006 |
Release Date:
May 12, 2009 |
Receipt Date:
June 30, 2009 (Closed) |
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to support intervention research on health disparities that is jointly conducted by communities and researchers. |
Title: Recovery Act Limited Competition: NCMHD Exploratory Centers of Excellence (P20) |
Announcement Number:
RFA-MD-09-007 |
Release Date:
May 12, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to eligible institutions/organizations that propose to establish an Exploratory NCMHD Center of Excellence (COE) that will provide funding for hiring staff, researchers, community members, and trainees with the goal of augmenting and expanding the capacity and infrastructure of the institution and community to engage in research improving the health of nation and for preparing the next generation of researchers. |
Title: Recovery Act Limited Competition: NCMHD Dissertation Research Award to Increase Diversity (R36) |
Announcement Number:
RFA-MD-09-008 |
Release Date:
May 12, 2009 |
Receipt Date:
June 30, 2009 (Closed) |
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to support qualified pre-doctoral students to pursue research careers in any area relevant to the research mission of the NCMHD (i.e., minority health and health disparities research) and simultaneously increase the diversity of this workforce. |
Challenge Grants
Title: Recovery Act Limited Competition: NIH Challenge Grants in Health and Science Research (RC1) |
Announcement Number:
RFA-OD-09-003 |
Release Date:
March 4, 2009 |
Receipt Date:
April 27, 2009 (Closed) |
Description: The NIH Challenge Grants in Health and Science Research will support new projects that address specific biomedical, behavioral and public health research challenges. There is one RFA for the Challenge Grants but many scientific topics that applications might address. Learn more about NCI's Challenge Grants topics at http://challenge.nci.nih.gov.
Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
|
Grand Opportunities (GO)
Title: Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure "Grand Opportunities" (RC2) |
Announcement Number:
RFA-OD-09-004 |
Release Date:
March 20, 2009 |
NEW Receipt Date:
May 29, 2009 (Closed) |
Note: The application deadline has been extended due to maintenance of the eRA Commons Web site. However, applications may be submitted to Grants.gov during this time (May 22-26).
Description: The Research and Research Infrastructure Grand Opportunities (GO) program will support high-impact, large-scale projects that lend themselves to short-term, non-renewable funding. NCI expects to devote $10,000,000 to support projects in areas such as nanotechnology, proteomics, stem cell research, early phase clinical trials, transcriptional and translational regulation, and comparative oncology research. See the following NCI announcements:
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: Identifying Potential Viral Signatures in Large Scale Studies of Germline and Somatic Changes in Cancer Genomes Pilot Program (PDF - 166KB).
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: Coordination of Clinical/Translational Research across the NCI (PDF - 39KB).
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: NCI Molecular Target Discovery and Development Centers Pilot Program (Updated May 8, 2009) (PDF - 37KB).
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: Comparative Effectiveness Research in Cancer Prevention, Screening and Treatment (PDF - 44KB).
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: Comparative Effectiveness Research in Genomic and Personalized Medicine (PDF - 46KB).
- NCI Guidelines for ARRA Research and Research Infrastructure Grand Opportunities: Exploratory Research in Development of Vaccines for AIDS-associated Malignancies (PDF - 55KB).
- NCI Guidelines for ARRA Research and Research Infrastructure "Grand Opportunities" (Updated April 24, 2009) (PDF 25KB) for a variety of scientific areas that include, but are not limited to, nanotechnology, proteomics, stem cells, early phase clinical trials, comparative oncology research, or transcriptional and translational regulation.
Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
|
Core Center Grants (P30)
Title: Recovery Act Limited Competition: Biomedical Research Core Centers to Enhance Research Resources (P30 - faculty recruitment) |
Announcement Number:
RFA-OD-09-005 |
Release Date:
March 24, 2009 |
Receipt Date:
May 29, 2009 (Closed) |
Description: This award is designed to support Core Center Grants. This program will provide funding to develop the resources necessary to conduct relevant research projects, including funds for hiring and providing appropriate start-up packages for newly-independent investigators. NCI expects to make up to a total of 10 awards with funding of approximately $8 million in total costs each year for the two year period FY2009 and FY2010. See NIH grant application guidelines for NCI Core Centers for Enhancing Research Capacity In U.S. Academic Institutions (P30).
Two additional (paper) copies of the application should be sent to the NCI at the address shown below:
Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov
|
Instrumentation
Title: Recovery Act Limited Competition: High-End Instrumentation Grant Program (S10) |
Announcement Number:
PAR-09-118 |
Release Date:
March 5, 2009 |
Receipt Date:
May 6, 2009 (Closed) |
Description:Groups of NIH-supported investigators may request funds to purchase a single major item of equipment to be used for biomedical research that costs at least $600,000. The maximum award is $8,000,000. |
Title: Addition of Recovery Funds to the Shared Instrumentation Grant Program |
Announcement Number:
PAR-09-028 |
Release Date:
November 14, 2008 |
Receipt Date:
March 23, 2009 (Closed) |
Description:This funding opportunity encourages applications for shared instrumentation and other capital research in the range of $100,000 to $500,000. |
Competitive Revisions and Administrative Supplements
Title: NIH Announces the Availability of Recovery Act Funds for Administrative Supplements |
Announcement Number:
NOT-OD-09-056 |
Release Date:
March 16, 2009 |
Receipt Date:
See guidelines for specific NCI program receipt dates. |
Description: Those with active NIH research grants may request administrative supplements to accelerate the tempo of scientific research on active grants. Specific areas of interest include: equipment purchases, increasing clinical trials enrollment and capacity for data analysis, research employment opportunities, and comparative effectiveness research. NCI will also be accepting supplement requests solely for small equipment (<$100K) purchases. See the National Cancer Institute (NCI) Guidelines for ARRA Administrative Supplements. |
Title: Administrative Supplements for Patient Navigators for the Cancer Care Continuum |
Announcement Number:
n/a |
Release Date:
May 11, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) for a patient navigator who helps guide patients through the medical care system. Applications are limited to those with NCI funding through the CRCHD from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP). See NCI Guidelines for Administrative Supplements for Patient Navigators for the Cancer Care Continuum (PDF 52KB). |
Title: Administrative Supplements for a Community Health Educator (CHE) for Outreach, Education, Coordination, and Evaluation |
Announcement Number:
n/a |
Release Date:
May 11, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) for a community health educator. Applications are limited to those with NCI funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for a Community Health Educator (CHE) for Outreach, Education, Coordination, and Evaluation (PDF 51KB). |
Title: Administrative Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers |
Announcement Number:
NOT-OD-09-056 |
Release Date:
May 1, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) to encourage individuals with high potential to re-enter an active research career after a qualifying interruption for family or other responsibilities. See NCI Guidelines for Administrative Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (PDF 35KB). |
Title: Administrative Supplements for Minority Biospecimen/Biobanking - Geographic Management Program (BMaP) |
Announcement Number:
n/a |
Release Date:
April 13, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement to create state-of-the art networks/centers dedicated to ensuring the adequate and continuous supply of high-quality human biospecimens from multi-ethnic communities for cancer research. Applications are limited to those with funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for Minority Biospecimen/Biobanking - Geographic Management Program (BMaP) (PDF 108KB). |
Title: Administrative Supplements for Transdisciplinary Geographic Management Program (GMaP) |
Announcement Number:
n/a |
Release Date:
April 13, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement to create state-of-the art regional networks/centers dedicated to cancer health disparities research and care. Applications are limited to those with NCI funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for Transdisciplinary Geographic Management Program (GMaP) (PDF - 106KB). |
Title: Administrative Supplements for Emerging Technologies Continuing Umbrella of Research Experiences (ET CURE) |
Announcement Number:
n/a |
Release Date:
April 13, 2009 |
Receipt Date:
July 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) to plan and implement a research training program to provide research training in emerging technologies (ET-CURE) for high school and undergraduate students from underserved populations. See NCI Guidelines for Administrative Supplements for the Emerging Technologies Continuing Umbrella of Research Experiences (ET CURE) (PDF - 240KB). |
Title: Administrative Supplements in Support of Expanding the Childhood Cancer TARGET Initiative |
Announcement Number:
NOT-OD-09-056 |
Release Date:
May 11, 2009 |
Receipt Date:
June 12, 2009 (Closed) |
Description: Those with active NIH research grants may apply for administrative supplements that will support expansion of The Childhood Cancer Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative to include additional pediatric cancers as well as furthering our understanding of treatment failure for acute lymphoblastic leukemia and neuroblastoma. The primary focus of the TARGET Initiative will remain identifying genomic alterations that offer rapid pathways to novel therapeutic interventions that may lead to more effective treatments. See NCI Guidelines for Administrative Supplements in Support of Expanding the Childhood Cancer TARGET Initiative (PDF 69KB). |
Title: Administrative Supplements for NCI Alliance for Nanotechnology in Cancer Grants and Cooperative Agreements |
Announcement Number:
NOT-OD-09-056 |
Release Date:
May 5, 2009 |
Receipt Date:
June 1, 2009 (Closed) |
Description: Those with active NIH research grants may apply for administrative supplements that will support efforts in the use of nanomaterials, nanotechnology tools, and devices towards applications in prevention, diagnosis, and therapy of cancer through specifically targeting job creation and retention through pursuing cancer proteomics research currently being conducted under funding of these awards. See NCI Guidance for Administrative Supplements for NCI Alliance for Nanotechnology in Cancer Grants and Cooperative Agreements (PDF 36KB). |
Title: Administrative Supplements for NCI Clinical Proteomic Technologies for Cancer Program |
Announcement Number:
NOT-OD-09-056 |
Release Date:
May 4, 2009 |
Receipt Date:
June 1, 2009 (Closed) |
Description: Those with active NIH research grants may apply for administrative supplements that will support the application of proteomic technologies in discovering and verifying biomarkers of early cancer detection and therapeutic outcomes through specifically targeting job creation and retention through pursuing cancer proteomics research currently being conducted under funding of these awards. See NCI Guidance for Administrative Supplements for NCI Clinical Proteomic Technologies for Cancer Program (PDF 32KB). |
Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications |
Announcement Number:
NOT-OD-09-058 |
Release Date:
March 18, 2009 |
Receipt Date:
April 21, 2009 (Closed) |
Description: Those with active NIH research grants may submit revision applications to support a significant expansion of scope or research protocol. Examples of the types of revisions may include addition of students, postdoctoral fellows, principal investigators, or other personnel as well as investments in technology essential to expand the goals of the project. Institutes have specific guidelines for applying for these funds; see the National Cancer Institute (NCI) Guidelines for ARRA Competitive Revisions. See also the National Center for Research Resources (NCRR) for NCRR specific application guidelines.
Released April 10, 2009: Notice NOT-OD-09-083 Competitive Revisions Using Recovery Act Funds for Applications Still Requiring Paper Submission for parent awards for which the activity code of the application has not transitioned to electronic submission.
As indicated in the NOT-OD-09-083 notice, two additional copies of the application (e.g., P01, P30, P50, U01, U10, etc.), which will be submitted on paper, should be sent to NCI as indicated below:
Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov
In a brief cover letter, please mention NOT-OD-09-058, which is the relevant funding opportunity announcement, the NCI-funded parent grant number, and the assigned NCI program director.
|
Title: NCI-Activities to Promote Research Collaborations (Administrative Supplements) |
Announcement Number:
n/a |
Release Date:
March 17, 2009 |
Receipt Date:
May 1, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for funding to support new multidisciplinary scientific collaborations among NCI grantees, as well as with other members of the scientific community, in cancer biology, cancer control and population sciences, cancer surveillance, cancer prevention, health services and outcomes research, and cancer treatment and diagnosis. See also NCI- APRC Guidelines and Information for Applicants (PDF - 65KB). |
Title: Administrative Supplement for Early Phase Imaging in Therapeutic Clinical Trials - Cancer Imaging Program |
Announcement Number:
n/a |
Release Date:
April 29, 2009 |
Receipt Date:
May 27, 2009 (Closed) |
Description: Those with NCI-funded research projects may apply for an administrative supplement to support early phase advanced imaging in therapeutic clinical trials under approved protocols or protocols that will be approved shortly that address the following scientific areas: 1) development of FLT-PET as a predictive marker in cancer therapy of solid-tumors, 2) NaF-PET as a pharmacodynamic biomarker, or 3) application of USPIOs to direct brain cancer therapy. Projects that address scientific areas 1 and 2 above should be ready for expansion to a multi-site study. Applicants are limited to those with existing grants under the U01, U10 (Cooperative Group Program), R01, P01, P30 (Cancer Center Support Grant) mechanisms. See NCI Guidelines for Administrative Supplements in Support of Early Phase Imaging in Therapeutic Clinical Trials- Cancer Imaging Program (PDF 208KB). |
Construction/Renovation
Title: Recovery Act Limited Competition: Extramural Research Facilities Improvement Program (C06) |
Announcement Number:
RFA-RR-09-008 |
Release Date:
March 5, 2009 |
Receipt Date:
May 6, 2009 (Closed) |
Description: Those with active NIH research grants may request administrative supplements to accelerate the tempo of scientific research on active grants. Specific areas of interest include: equipment purchases, increasing clinical trials enrollment and capacity for data analysis, research employment opportunities, and comparative effectiveness research. |
close
For financial and grants management-related questions or inquiries please contact:
Office of Grants Administration (OGA)
Crystal Wolfrey, Grants Branch Chief
Grants Management Specialist, OGA
National Cancer Institute, NIH, HHS
Telephone: 301-496-8634
Fax: 301-846-5720
E-mail: wolfreyc@mail.nih.gov
|